| INTRODUCTION
The Prickle Planar Cell Polarity Protein 1 (PRICKLE1-MIM 608500) gene is involved in a calcium mediated regulation of planar neuronal polarity signaling during embryonic development as well as in neuronal morphogenesis, migration, and networking (Bassuk et al., 2008) .
PRICKLE1-related phenotypes not only include autosomal recessive progressive myoclonus epilepsy (PME)-ataxia syndrome (MIM 612437) and neural tube defects associated with heterozygous mutations but also agenesis of corpus callosum, polymicrogyria, and autistic spectrum disorder (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) . The broad heterogeneity of the phenotypic spectrum could be explained by a dosage effect involving the encoded protein for patients carrying heterozygous variants and by the variable degrees of impairment that may occur in the cascade of signals modulated by PRICKLE1 in the other cases (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) .
Early clinical characterization of these rare disorders is limited.
We report on a young boy with a new PRICKLE1 mutation presenting with early infantile epileptic encephalopathy and reviewed the cases so far reported in the literature.
| CLINICAL REPORT
This 25-month-old boy was born from nonconsanguineous Indian parents after an uneventful pregnancy and labor. Family history evidenced a single relative in the maternal line with drug-responsive tonic seizures during childhood. The child's psychomotor development before the epilepsy onset was normal.
At the age of 10 months, he manifested prolonged daily clusters of head-nodding attacks and myoclonic jerks. After the age of 13 months, tonic and focal motor seizures also appeared and progressive developmental delay became apparent (at the age of 14 months Griffith's Mental Developmental Scales DQ was less than 50) with reduced alertness, poor social interactions, and feeding. Despite ataxia, the child could still walk unsupported at 18 months of age. No notable dismorphic features or other non-neurological signs and symptoms were observed. Ictal electroencephalogram (EEG) revealed generalized delta activity associated with diffuse epileptiform discharges. Interictal EEGs showed multifocal spikes and sharp waves. Both parents were heterozygous carriers of the mutation. Note. F = female; M = male; HOM = homozygous; HET = heterozygous; NR = not reported; yr = years; mo = months; DQ = developmental quotient. Table 1 summarizes mutational data and clinical characteristics of the patients with PRICKLE1-related encephalopathy so far reported (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) . PME has been reported in 23 subjects with homozygous variants and in two patients with heterozygous variants (Table 1; Ehaideb et al., 2014; Paemka et al., 2015; Tao et al., 2011) .
A positive neurocognitive outcome and a complete or partial responsiveness to valproate were reported in almost all cases (Table 1; Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) . In some patients (patients 4, 7, and 8 in Table 1 and the case reported here) a minor efficacy of antiepileptic treatment was observed even if no specific phenotypic feature was highlighted as a reliable predictor for an optimal responsiveness (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) .
The patients so far reported presented a later onset of seizures (mean age higher than 4 years with the significant exception of patient 34 in Table 1 who was a 7-month-old male carrying a de novo mutation and presenting with myoclonic seizures) and a less severe epilepsy than our patient (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) .
Epilepsy with pleomorphic seizures and concomitant developmental arrest suggested the diagnosis of epileptic encephalopathy in our patient. Seizures-related developmental and cognitive impairment have not been mentioned as part of the PRICKLE1-related phenotypes even though a systematic neurodevelopmental evaluation has not been performed in the previously reported patients (Table 1; Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018) . which had been detected in a patient with neural tube defect and hydrocephalus but no epilepsy (Bosoi et al., 2011) .
The role of PRICKLE1 in different aspects of embryo neurodevelopment would suggest that cognitive and neurological functions can be impaired as a direct consequence of the defective protein, although severe epilepsy might have worsened the clinical picture (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011) .
Moreover, the alterations of neuronal signaling and networking cascades in which PRICKLE1 is involved may result in dysfunctions of RE-1 silencing transcription factor or ubiquitin-specific peptidase 9
X-linked, which may as such contribute to the worsening of cognitive status (Bassuk et al., 2008; Paemka et al., 2015; Todd & Bassuk, 2018) .
| CONCLUSIONS
This clinical report highlights the fact that in the context of an epileptic encephalopathy with developmental arrest, early onset severe PME-ataxia syndrome can be a PRICKLE1-associated phenotype.
